Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01483378 · ClinicalTrials.gov registry record · NA
Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 170
- Enrollment target
NCT01483378 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 170 participants.
The verdict
NCT01483378, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if vaccination rate of eligible patients at a major urban public hospital will increase by having ophthalmologists screen patients for eligibility and a nurse administer the vaccine in the General Eye Clinic.
Interventions
- OTHER Choosing to receive the vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01483378
The ClinicalTrials.gov registry entry for NCT01483378 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Choosing to receive the vaccine is the first listed.
NCT01483378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01483378 about?
NCT01483378 is a clinical study titled "Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital". The purpose of this study is to determine if vaccination rate of eligible patients at a major urban public hospital will increase by having ophthalmologists screen patients for eligibility and a nurse administer the vaccine in the General Eye Clinic.
What is the current status of trial NCT01483378?
This trial is currently completed. It is a NA study. The enrollment target is 170 participants. The study started on 2012-01. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01483378?
The interventions under investigation include: Choosing to receive the vaccine (OTHER).
Who is sponsoring clinical trial NCT01483378?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.